Simple Summary Cholangiocarcinoma constitutes around 3% of gastrointestinal cancers,
and mortality from this cancer has been rising in the recent decades. Many cases of …

Introduction: Surgical resection remains the mainstay of potentially curative treatment in the
early stages of cholangiocarcinoma, whereas for the advanced stage, systemic …

Primary tumor resection and liver transplantation are the only curative treatment options for
the management of cholangiocarcinoma (CCA). However, for patients with advanced or …

Cholangiocarcinoma (CCA) is a highly-aggressive malignancy arising from the biliary tree,
characterized by a steady increase in incidence globally and a high mortality rate. Most …

Cholangiocarcinoma (CCA), a group of malignancies that originate from the biliary tract, is
associated with a high mortality rate and a concerning increase in worldwide incidence. In …

Cholangiocarcinoma is a spectrum of invasive adenocarcinomas that arise in the
intrahepatic, perihilar, or distal biliary tree, and is classified by location. During JADPRO Live …

Cholangiocarcinoma (CCA) is a malignant tumor originating in the bile duct and its
branching epithelium. Due to its high heterogeneity, there are no specific clinical indications …

Objective Many patients with cholangiocarcinoma (CCA) are not surgical candidates, and
the survival benefit of chemotherapy is less than 12 months. Several mutations and …

Introduction Cholangiocarcinoma is a malignant disease of the biliary tract and accounts for
3% of all gastrointestinal tumors. Surgical intervention is currently the only potentially …

Simple Summary This paper delves into the latest developments in the emerging therapies
for cholangiocarcinoma, with a focus on precision medicine, immunotherapy, and targeted …